EP2913048A1 — Pharmaceutical composition comprising trametinib
Assigned to Ratiopharm GmbH · Expires 2015-09-02 · 11y expired
What this patent protects
The present invention relates to a pharmaceutical composition comprising trametinib or a pharmaceutically acceptable salt thereof as active ingredient and a carrier. The invention further relates to an intermediate for the preparation of said pharmaceutical composition and a meth…
USPTO Abstract
The present invention relates to a pharmaceutical composition comprising trametinib or a pharmaceutically acceptable salt thereof as active ingredient and a carrier. The invention further relates to an intermediate for the preparation of said pharmaceutical composition and a method of preparing said pharmaceutical composition or said intermediate.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.